The devil is in the details...or not? A primer on individual patient data meta-analysis

Evidence-Based Medicine

Volumn 14, Issue 4, 2009, Pages 100-101

  Sud, Sachin ^a   Douketis, James ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; CARDIAC PATIENT; DATA BASE; PATIENT INFORMATION; RANDOM ERROR; SHORT SURVEY;

EVIDENCE-BASED MEDICINE; META-ANALYSIS AS TOPIC;

EID: 68149156091     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm.14.4.100     Document Type: Short Survey

References (14)

1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188
2. Sutton AJ, Abrams KR, Jones DR, et al. Methods for meta-analysis in medical research. Chichester, UK: John Wiley and Sons, 2000.
3. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. Journal of the Royal Statistical Society Series A 1988;151:419-463
4. Higgins JP, Green S, editors. Identifying and measure heterogeneity. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Collaboration, 2005. www.rees-france.com/IMG/pdf/2005- handbookcochrane- systematic-review-.pdf (accessed 20 May 2009).
5. Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005;34:79-87.
6. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
7. Chalmers I. The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Ann N Y Acad Sci 1993;703:156-163 (Pubitemid 24149534)
8. Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002;25:76-97.
9. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998;97:2202-2212
10. Berlin JA, Santanna J, Schmid CH, et al, for the Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med 2002;21:371-387
11. Lambert PC, Sutton AJ, Abrams KR, et al. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002;55:86-94.
12. Williamson PR, Marson AG, Tudur C, et al. Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials. J Eval Clin Pract 2000;6:205-214 (Pubitemid 30615011)
13. Simmonds MC, Higgins JP, Stewart LA, et al. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005;2:209-217
14. Stewart LA, Tierney JF, Clarke M. Chapter 19. Reviews of individual patient data. In: Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008.